Skip to main content

Major Depressive Disorder

After a Breakthrough Therapy guidance meeting with the US Food & Drug Administration (FDA), Sage Therapeutics announced plans to launch 3 additional studies of its investigational drug zuranolone.
Researchers have developed a machine learning algorithm that uses electroencephalogram (EEG) data to predict whether a selective serotonin reuptake inhibitor (SSRI) is likely to benefit a patient.
An interactive voice application’s assessment of patient well-being through analysis of their speech was highly comparable with physicians’ tracking of patient well-being, according to a study published online in PLOS One.
Resting-state electroencephalographic (EEG) data may help in predicting the outcome of escitalopram treatment in patients with major depressive disorder (MDD), suggests a study published online in JAMA Network Open.
Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses how frequently patients can cycle between depression and mania.
Two members of the Psych Congress Steering Committee have been featured on an ABC News podcast which grew out of a newsman's newfound interest in meditation.
Listen as Psych Congress Steering Committee member Charles Raison, MD, discusses a book he coauthored, The New Mind-Body Science of Depression, with David Van Nuys, PhD, on Shrink Rap Radio.
Listen to Charles Raison, MD, discuss his JAMA Psychiatry study examining the relationship between inflammation and depression.
Back to Top